Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1500648800HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

Exelixis's oncology ambitions on track with European Cometriq approval

26.03.2014 / Scripintelligence

Similar to AstraZeneca's Caprelsa, which is also approved in this setting, the label states that for patients in whom the 'rearranged during transfection' (RET) mutation status is not known or is negative, a possible lower benefit should be considered…

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: